1. Versatile role of curcumin and its derivatives in lung cancer therapy
   Milad Ashrafizadeh et al, 2020, Journal of Cellular Physiology CrossRef
2. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
   Joshua E. Reuss et al, 2021, Clinical Lung Cancer CrossRef
3. The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization
   Devivasha Bordoloi et al, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef
4. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL
   Keisuke Iida et al, 2017, Scientific Reports CrossRef
5. Curcumin Nanoemulsion: Evaluation of Stability and Anti-Cancer Activity In Vitro
   Thanh Binh Nguyen et al, 2020, Journal of Nano Research CrossRef
6. Mistletoe ( Viscum album ) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells
   Soyoung Kim et al, 2017, Phytomedicine CrossRef
7. Antibody–drug conjugates for lung cancer in the era of personalized oncology
   Biagio Ricciuti et al, 2021, Seminars in Cancer Biology CrossRef
8. Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
   Dan Yan et al, 2021, Cancers CrossRef
9. Giving AXL the axe: targeting AXL in human malignancy
   Carl M Gay et al, 2017, British Journal of Cancer CrossRef
10. Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma
    Mahsa Salehi et al, 2020, Phytotherapy Research CrossRef
11. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
    Alessandro Allegra et al, 2017, Cancer Investigation CrossRef
12. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
    Chenjing Zhu et al, 2019, Molecular Cancer CrossRef
13. Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
    Sayali Bhave et al, 2021, Biomedicines CrossRef
14. Nanoscale Formulations: Incorporating Curcumin into Combination Strategies for the Treatment of Lung Cancer
    Quhui Wu et al, 2021, Drug Design, Development and Therapy CrossRef
15. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance
    Hongmei Cui et al, 2020, Current Medicinal Chemistry CrossRef
16. MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
    Sagar L. Patil et al, 2019, Scientific Reports CrossRef
17. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway
    Liang Hao et al, 2016, Biochemical and Biophysical Research Communications CrossRef
18. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects
    Milad Ashrafizadeh et al, 2020, Life Sciences CrossRef